341 – 350 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia
(
- Contribution to journal › Article
-
Mark
Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?
(
- Contribution to journal › Article
-
Mark
Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients.
(
- Contribution to journal › Letter
-
Mark
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
(
- Contribution to journal › Letter
-
Mark
Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy
(
- Contribution to journal › Article
-
Mark
Interleukin-6-deficient mice develop mature-onset obesity
(
- Contribution to journal › Article
-
Mark
Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta -cell exocytosis and release of insulin.
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model.
(
- Contribution to journal › Article
-
Mark
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
(
- Contribution to journal › Article
- 2001
-
Mark
Direct cytoplasmic CA(2+) responses to gastrin-releasing peptide in single beta cells
(
- Contribution to journal › Article